Terminated PHASE4 INTERVENTIONAL 2-arm NCT00177424

Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation Outcomes

Intervention to Prevent Post-Stroke Major Depression.

Sponsor: National Institute of Mental Health (NIMH)

Conditions Cerebrovascular Accident Depression

Updated 5 times since 2017 Last updated: Jun 26, 2014 Started: Jul 31, 2004 Primary completion: Oct 31, 2007 Completion: Oct 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Recruitment goals could not be met.

Other terminated trials from National Institute of Mental Health (NIMH)

See all terminations from National Institute of Mental Health (NIMH)

Other Cerebrovascular Accident trials with similar outcome

NCT00396058 · Phase PHASE4 · Mar 2008

Browse all Cerebrovascular Accident trials

A PHASE4 clinical study on Cerebrovascular Accident and Depression, this trial is terminated or withdrawn. The trial is conducted by National Institute of Mental Health (NIMH) and has accumulated 5 data snapshots since 2004. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Jul 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)
University of Pittsburgh

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States